Loading…
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma
Mammalian genomes encode numerous antisense non-coding RNAs, which are assumed to be involved in the regulation of the sense gene expression. However, the mechanisms of their action and involvement in the development of diseases have not been well elucidated. The ANA/BTG3 protein is an antiprolifera...
Saved in:
Published in: | Scientific reports 2013-02, Vol.3 (1), p.1305, Article 1305 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mammalian genomes encode numerous antisense non-coding RNAs, which are assumed to be involved in the regulation of the sense gene expression. However, the mechanisms of their action and involvement in the development of diseases have not been well elucidated. The ANA/BTG3 protein is an antiproliferative protein whose expression is downregulated in prostate and lung cancers. Here we show that an antisense transcript of the
ANA/BTG3
gene, termed
ASBEL
, negatively regulates the levels of ANA/BTG3 protein, but not of
ANA/BTG3
mRNA and is required for proliferation and tumorigenicity of ovarian clear cell carcinoma. We further show that knockdown of ANA/BTG3 rescues growth inhibition caused by
ASBEL
knockdown. Moreover, we demonstrate that
ASBEL
forms duplexes with
ANA/BTG3
mRNA in the nucleus and suppresses its cytoplasmic transportation. Our findings illustrate a novel function for an antisense transcript that critically promotes tumorigenesis by suppressing translation of the sense gene by inhibiting its cytoplasmic transportation. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep01305 |